Tag | Content |
---|
EnhancerAtlas ID | HS175-11134 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr17:7035780-7036680 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr17:7035813-7035834 | AAAGAAAAAGAGGAACTAAAA | - | 6.32 | NR2C2 | MA0504.1 | chr17:7036015-7036030 | TGACCCCTGACCCCT | - | 7.2 | SPI1 | MA0080.4 | chr17:7035817-7035831 | AAAAAGAGGAACTA | + | 6.66 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_09336 | chr17:7032154-7043631 | CD14 | SE_68171 | chr17:7013178-7041452 | TC32 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr17 | 7035816 | 7036492 | chr17 | 7035868 | 7036444 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I007130 | chr17 | 7033542 | 7037519 |
|
Enhancer Sequence | AAAAAAAAAA GAAAGAAAGA AAGAAAGAAA AGAAAAGAAA AAGAGGAACT AAAAAGAGCT 60 CAATTTGGGA TAGACGGTGT TTGTGTTTGA GGTCCCTGTT AGACCCTAAG GTGAGATGCC 120 AGGGCAGAAG CTGAATAAAC AATCCAGGCA GGAACACACA CTCACACACA TTGACCCCAA 180 TCCCATGAGC CCCATTGTCC TGAAGACACA TCCCTGCTCC TGCCCAGCTG GTCCCTGACC 240 CCTGACCCCT GGCTATGCTG GCCTCAGATC TGTGTCTCCT TCTCAAGTCA TTGGCCCCCA 300 GGGCCACTGT CCCTCCGTCT CCACTGGGTG CACTGGAAAG GCAGGGTGAG GTACAAGAAG 360 CCCCATTTAA AACCATGAAA TCAGCAGCTC AAACACCAGA AAGTCCCCAG CTTTTGCAAC 420 AGCTCATAAG GACTGGTGTT TCCTGCGAGC AGTGACACCC TGCAGGTTTC TAAACTCTGC 480 TTCTCTTTGT TTTGTAAAGC AGTGTTCTAT CAGTCCCGGA AAGCCCCTGG AGTGGATCAC 540 GCCTCCCTAA TCTACCGTGT TCTGCATTTA TCTGCATCTG CAATGTTTGT TGTGGTCTTG 600 TTGCTAGAGG CCTCGTTCCC CCTGCCTGGT TTATAAAATC CATGTAACCC AGGATTTTTT 660 GTGGTGTGGA TACTCTACAT TGAAAGGACA TGCATGCTTT CTATTTTATT TATTTATTTA 720 TTTATTATTT TTATTTTTAT TTTTATTTTT GGAGACGGAG TCTGGCTCTG TTGCCAGGCT 780 GGAGTGCAGT GGCGCGATCT CGGCTCACTG CAACCTCCAC CTCCCAGGTT CAAGCGATTC 840 TCCTGTCTCA GCCTCCCGAG TCGCTGGGAC TACAGGCGCT CGCCGCCACG CCTGGCTAAT 900
|